Recurrent or Refractory T/NK-cell Malignancies
1 clinical trials · Condition
◉ Watch Recurrent or Refractory T/NK-cell Malignancies
| Record | Firm | Date |
|---|---|---|
| Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies (NCT00823355) | Mundipharma K.K. | 2009-01-01 |
Track Recurrent or Refractory T/NK-cell Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.